By
Adrianne Appel2025-08-04T18:13:00
The chief executive and medical director of Fast Lab Technologies allegedly engaged in a $500 million fraud scheme involving COVID-19 tests, the U.S. Department of Justice (DOJ) said.
Fast Lab CEO Cemhan “Jimmy” Biricik and medical director, Martin Perlin, M.D., created the business and its website in 2021, during the height of the pandemic, and advertised “free” COVID-19 tests.
Fast Lab, based in New York, collected individuals’ insurance information and used it to fraudulently bill private insurers and federal health programs, including Medicare, Medicaid, and TRICARE, for COVID-19 testing that never took place, the DOJ alleged.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2025-11-19T14:10:00Z By Adrianne Appel
Horizon Blue Cross Blue Shield of New Jersey has agreed to pay $100 million to settle allegations that its 2020 contract with the state was fraudulent, according the state’s Attorney General.
2025-10-03T21:24:00Z By Adrianne Appel
While the Trump administration may have shifted away from pursuing small, white-collar, financial crimes, its focus on health care fraud cases is as hot as ever.
2025-09-05T21:03:00Z By Aly McDevitt
Nestlé dismissed its CEO over an undisclosed relationship with a subordinate, a clear breach of the company’s code of business conduct. The dismissal underscores that no one is exempt from compliance obligations, even top leadership.
2026-03-19T21:08:00Z By Aaron Nicodemus
The U.S. Securities and Exchange Commission’s Mark Uyeda told an audience of investment advisers that the SEC will no longer prioritize stand-alone enforcement actions for violations of the SEC’s rules on off-channel communications.
2026-03-17T21:22:00Z By Oscar Gonzalez
Adobe agreed to a $150 million settlement with the U.S. Department of Justice over accusations that it concealed software termination fees and made it difficult for customers to cancel.
2026-03-13T21:06:00Z By Neil Hodge
New powers granted to the U.K.’s main competition watchdog will result in greater scrutiny, tougher enforcement, and a stark warning for companies to review their sales and marketing promotions—especially since some practices have been pushed firmly into the spotlight thanks to legislation that came into effect last year.
Site powered by Webvision Cloud